Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ADHD
MedTech
Akili cuts workforce another 40%, eyes OTC digital app model
In its latest attempt to weather the digital therapeutics storm, Akili is taking a new tack, one that will help it avoid relying on payers at all.
Andrea Park
Sep 14, 2023 10:35am
Akili's video game ADHD treatment now available for adults
Jun 7, 2023 3:05pm
Akili aims to expand its videogame ADHD treatment to adults
May 3, 2023 1:00pm
Akili axes 46 workers, slims prescription video game pipeline
Jan 17, 2023 10:40am
In struggling Vallon, GRI Bio spots opportunity to reach Nasdaq
Dec 14, 2022 8:27am
Study brings Akili's ADHD digital therapeutic tech to lupus
Jul 15, 2022 10:35am
